Stocktoria
Beta Bionics, Inc. BBNX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-01-30
Chart by TradingView
4/9
Piotroski F — financial health
6.94
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $100.3M | $65.1M | $12.0M |
| Gross profit | $55.5M | $35.9M | $6.3M |
| Operating income | -$71.7M | -$45.3M | -$35.9M |
| Net income | -$73.2M | -$54.8M | -$44.1M |
| Operating cash flow | -$50.9M | -$48.3M | -$32.4M |
| Free cash flow | -$56.2M | -$51.7M | -$32.8M |
| Total assets | $328.7M | $149.6M | $110.0M |
| Total liabilities | $41.1M | $73.6M | $51.4M |
| Shareholders' equity | $287.6M | -$245.4M | -$203.1M |
| Ratios | |||
| Gross margin | 55.4% | 55.1% | 52.6% |
| Operating margin | -71.5% | -69.5% | -298.9% |
| Net margin | -73.0% | -84.1% | -367.6% |
| FCF margin | -56.1% | -79.3% | -273.8% |
| Return on assets | -22.3% | -36.6% | -40.1% |
| Return on equity | -25.5% | 22.3% | 21.7% |
| Current ratio | 8.66 | 6.29 | 9.77 |
| Revenue growth | 53.9% | 442.9% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 2,525,040 | $25.3M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 6.94 (safe)
- Working capital / assets 0.721
- Retained earnings / assets -1.125
- EBIT / assets -0.218
- Equity / liabilities 6.992
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001674632 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.